These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1045 related items for PubMed ID: 25751200
1. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Bristow RE, Chang J, Ziogas A, Campos B, Chavez LR, Anton-Culver H. Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200 [Abstract] [Full Text] [Related]
2. Racial disparities in the treatment of advanced epithelial ovarian cancer. Howell EA, Egorova N, Hayes MP, Wisnivesky J, Franco R, Bickell N. Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782 [Abstract] [Full Text] [Related]
3. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status. Bristow RE, Chang J, Ziogas A, Anton-Culver H, Vieira VM. Gynecol Oncol; 2014 Jul; 134(1):60-7. PubMed ID: 24680770 [Abstract] [Full Text] [Related]
4. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. Bristow RE, Powell MA, Al-Hammadi N, Chen L, Miller JP, Roland PY, Mutch DG, Cliby WA. J Natl Cancer Inst; 2013 Jun 05; 105(11):823-32. PubMed ID: 23539755 [Abstract] [Full Text] [Related]
5. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer. Chen F, Bailey CE, Alvarez RD, Shu XO, Zheng W. Gynecol Oncol; 2021 Jan 05; 160(1):10-15. PubMed ID: 33208254 [Abstract] [Full Text] [Related]
6. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California. Pfaendler KS, Chang J, Ziogas A, Bristow RE, Penner KR. Obstet Gynecol; 2018 May 05; 131(5):899-908. PubMed ID: 29630020 [Abstract] [Full Text] [Related]
7. Racial and socioeconomic disparities in survival among women with advanced-stage ovarian cancer who received systemic therapy. Washington CJ, Karanth SD, Wheeler M, Aduse-Poku L, Braithwaite D, Akinyemiju TF. Cancer Causes Control; 2024 Mar 05; 35(3):487-496. PubMed ID: 37874478 [Abstract] [Full Text] [Related]
8. Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer? Dilley S, Erickson BK, Phillips CE, Kennemer CR, Zhang B, Matin T, Martin JY, Shah MM, Michael Straughn J, Leath CA. Gynecol Oncol; 2018 Apr 05; 149(1):49-52. PubMed ID: 29605050 [Abstract] [Full Text] [Related]
9. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment. Kaspers M, Llamocca E, Quick A, Dholakia J, Salani R, Felix AS. Am J Obstet Gynecol; 2020 Sep 05; 223(3):398.e1-398.e18. PubMed ID: 32142825 [Abstract] [Full Text] [Related]
10. Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer. Du XL, Sun CC, Milam MR, Bodurka DC, Fang S. Int J Gynecol Cancer; 2008 Sep 05; 18(4):660-9. PubMed ID: 17892451 [Abstract] [Full Text] [Related]
12. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival. Bristow RE, Chang J, Ziogas A, Campos B, Chavez LR, Anton-Culver H. J Am Coll Surg; 2015 May 05; 220(5):940-50. PubMed ID: 25840536 [Abstract] [Full Text] [Related]
13. The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois. Brewer KC, Peterson CE, Davis FG, Hoskins K, Pauls H, Joslin CE. Ann Epidemiol; 2015 Aug 05; 25(8):556-63. PubMed ID: 25986734 [Abstract] [Full Text] [Related]
14. A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals. Bristow RE, Chang J, Villanueva C, Ziogas A, Vieira VM. Obstet Gynecol; 2020 Feb 05; 135(2):328-339. PubMed ID: 31923082 [Abstract] [Full Text] [Related]
16. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease. Bristow RE, Chang J, Ziogas A, Randall LM, Anton-Culver H. Gynecol Oncol; 2014 Feb 05; 132(2):403-10. PubMed ID: 24361578 [Abstract] [Full Text] [Related]